Differentiation of imatinib -resistant chronic myeloid leukemia cells with BCR-ABL-T315I mutation induced by Jiyuan Oridonin A.

导出 OA

翻译打印收藏纠错

作者： Yun,Xu ^[1] ; Ziting,Wang ^[1] ; Lei,Zhang ^[1] ; Congying,Gao ^[1] ; Fahui,Li ^[1] ; Xueming,Li ^[1] ; Yu,Ke ^[2] ; Hong-Min,Liu ^[2] ; Zhenbo,Hu ^[3] ; Liuya,Wei ^[1] ; Zhe-Sheng,Chen ^[4]

作者单位： School of Pharmacy, Weifang Medical University, Weifang, 261053, China. ^[1] School of Pharmacy, Zhengzhou University, Zhengzhou, 450052, China. ^[2] Laboratory for Stem Cell and Regenerative Medicine, Affiliated Hospital of Weifang Medical University, Weifang 261042, China. ^[3] Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, 11439, USA. ^[4]

关键词 BCR-ABL oncogene Chronic myeloid leukemia T315I mutation cell differentiation imatinib-resistant BCR-ABL mutations

DOI 10.7150/jca.83219

PMID 37215441

发布时间 2023-05-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交